trunkmonk
15 minutes ago
looks like that guy is only one that can make out with wealth, he must be a libtard. Issue is, the decision has been made, even if the fine went up, its would be against Ripple pockets, including cofounder, stupid is a stupid does.
MartinLutherKing
16 minutes ago
TransCode’s lead therapeutic candidate, TTX-MC138, is a targeted therapy designed to treat cancer patients with metastatic cancer, an area traditionally overlooked because, from a therapeutic perspective, non-metastatic and metastatic tumor cells are often viewed as being the same. However, despite